In comparison to previous periods, a larger fraction of the pediatric population hospitalized due to respiratory syncytial virus infections between 2022 and 2023 was two to five years of age (34% ...

Children’s hospitals in the D.C. area have been full for weeks, with patients stacking up in emergency departments as a surge in respiratory illnesses exacerbates the strain of staff shortages ...

Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus ...